Title:

Current trends in biotechnology of drugs applied in cardiovascular diseases— recombinant proteins, peptide analogues and antisense oligonucleotides

Subtitle:

Current trends in biotechnology of drugs applied in cardiovascular diseases— recombinant proteins, peptide analogues and antisense oligonucleotides

Creator:

Cierniewski, Czesław S. ; Stasiak, Marta

Publisher:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Date issued/created:

1996

Subject and Keywords:

biotechnology

Abstract:

This lecture consists of three parts, the first one gives a summary of mechanisms regulatinghemostasis and fibrinolysis, the second — discusses potential target molecules for therapeuticintervention, and the third one describes recent studies on selective inhibition of certain pathophysiological processes by molecules designed to prevent cardiovascular problems. Thus, acritical review of current trends in biotechnology of drugs which recently have been designedand tested to improve survival of patients with different cardiovascular diseases is provided.

Relation:

Biotechnologia, vol.34, 3 (1996)-.

Volume:

34

Issue:

3

Start page:

11

End page:

22

Resource type:

Text

Detailed Resource Type:

Article

Format:

application/pdf

Resource Identifier:

0860-7796 ; IChB B-30

Source:

Library of Institute of Bioorganic Chemistry PAS

Language:

pol

Language of abstract:

eng

Temporal coverage:

1988-2010

Rights:

Creative Commons Attribution BY-SA 4.0 license

Terms of use:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitizing institution:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Original in:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Projects co-financed by:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Access:

Open